The use of in vivo confocal microscopy to track treatment success in fungal keratitis and to differentiate between Fusarium and Aspergillus keratitis.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 04 03 2019
accepted: 28 10 2019
pubmed: 9 11 2019
medline: 8 1 2021
entrez: 9 11 2019
Statut: ppublish

Résumé

To evaluate the usefulness of serial in vivo confocal microscopy (IVCM) examinations to measure hyphal density for monitoring the treatment success among patients with fungal keratitis, and to compare the hyphal diameter as well as branching angle as a way of differentiation between Aspergillus and Fusarium species observed in IVCM. Prospective nonrandomized study. The study was conducted from February 2015 to September 2016. Hyphal diameter, density and branching angle measurements were performed using IVCM at admission and on a weekly basis for at least 2 weeks after the start of treatment. During the period of study, 65 patients with culture-confirmed fungal keratitis were recruited. Of them, 40 were culture-positive for Fusarium spp. and 25 patients for Aspergillus spp. Before the start of treatment, the mean branching angle did not differ between the two species and the mean hyphal diameter was statistically higher for Aspergillus spp. (p = 0.029). Two weeks after the start of treatment, the mean hyphal diameter was statistically lower (p < 0.001) in the treatment failure group. Also the hyphal density significantly decreased with successful treatment (p < 0.05). Decreasing hyphal density in serial IVCMs might be used as an indicator to predict the successful response of fungal ulcers to treatment. Branching angle is not different between Aspergillus and Fusarium keratitis. The mean hyphal diameter is significantly lower in the treatment failure group.

Identifiants

pubmed: 31701361
doi: 10.1007/s10792-019-01209-2
pii: 10.1007/s10792-019-01209-2
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-491

Références

Br J Ophthalmol. 2007 May;91(5):588-91
pubmed: 17151059
Br J Ophthalmol. 2003 Apr;87(4):409-10
pubmed: 12642300
Cornea. 1997 Jan;16(1):27-31
pubmed: 8985630
J Fr Ophtalmol. 2016 Dec;39(10):843-848
pubmed: 27839848
Mycoses. 2018 Dec;61(12):916-930
pubmed: 29992633
Eye Contact Lens. 2006 Dec;32(6):267-71
pubmed: 17099386
Ophthalmology. 2014 Aug;121(8):1495-500.e1
pubmed: 24746358
Int J Ophthalmol. 2014 Feb 18;7(1):114-7
pubmed: 24634875
Med Mycol. 2010 Sep;48(6):886-8
pubmed: 20092421
Mycoses. 2008 May;51(3):183-99
pubmed: 18399899
Burns. 2007 May;33(3):341-6
pubmed: 17321689
Clin Microbiol Rev. 2003 Oct;16(4):730-97
pubmed: 14557297
BMC Ophthalmol. 2011 Dec 22;11:39
pubmed: 22188671
Am J Ophthalmol. 2018 May;189:41-46
pubmed: 29438654
Br J Ophthalmol. 2017 Aug;101(8):1119-1123
pubmed: 28043985
Eye (Lond). 2012 Sep;26(9):1226-31
pubmed: 22744392
Cornea. 2010 Dec;29(12):1346-52
pubmed: 20847667

Auteurs

Seyed Ali Tabatabaei (SA)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Soleimani (M)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Soleimani_md@yahoo.com.

Seyed Mehdi Tabatabaei (SM)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Amir Houshang Beheshtnejad (AH)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Niloufar Valipour (N)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Shahram Mahmoudi (S)

Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH